KromaTiD announces successful conclusion of Series A funding round

KromaTiD announces successful conclusion of Series A funding round

DENVER -- KromaTiD, Inc. announced it successfully completed its A round of financing withDenver-based firm First Capital Ventures. KromaTiD said its traction and potential within the... Read More

Wednesday August 14, 2019 0 comments Tags: Longmont, KromaTid

KromaTiD appoints Christopher Tompkins new company chief executive

KromaTiD appoints Christopher Tompkins new company chief executive

LONGMONT -- KromaTiD, Inc. announced the appointment of Christopher Tompkins as CEO. Tompkins, who joined the company in 2010, most recently served as president, GM and chief technology... Read More

Wednesday June 26, 2019 0 comments Tags: Longmont, KromaTid, Christopher Tompkins

KromaTiD receives $900K in funding from Human Genome Research Institute

KromaTiD receives $900K in funding from Human Genome Research Institute

FORT COLLINS-- KromaTiD, Inc . announced that after successfully meeting Phase 1 grant milestones, the company has been awarded Phase 2 funding from a Fast Track Small Business Innovation... Read More

Wednesday April 24, 2019 0 comments Tags: Fort Collins, KromaTid, Christopher Tompkins

KromaTiD announces opening of new corporate headquarters in Longmont

KromaTiD announces opening of new corporate headquarters in Longmont

LONGMONT -- KromaTiD, Inc. today announced the opening of the companys new corporate headquarters inColorado'sBoulder Countybiotech hub. The new facility includes corporate offices as well... Read More

Thursday March 28, 2019 0 comments Tags: Longmont, KromaTid, Christopher Tompkins

KromaTID awarded Fast Track Small Business Innovation Research grant

KromaTID awarded Fast Track Small Business Innovation Research grant

FORT COLLINS -- KromaTiD, Inc . announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Human Genome Research Institute. The SBIR program... Read More

Wednesday August 15, 2018 0 comments Tags: Fort Collins, KromaTid, Christopher Tompkins

KromaTiD announces close of Series A fund round

KromaTiD announces close of Series A fund round

FORT COLLINS -- KromaTiD announced the successful closure of a Series A financing round. KromaTiD, provider of Directional Genomic Hybridization and Pinpoint FISH products, said it... Read More

Wednesday June 21, 2017 0 comments Tags: Fort Collins, KromaTid, Terry Opgenorth, Pinpoint FISH, Directional Genomic Hybridization, Christopher Tompkins, CSU Ventures

Rockies Venture Club to host investment program at Galvanize FoCo Oct. 5

Rockies Venture Club to host investment program at Galvanize FoCo Oct. 5

FORT COLLINS -- Rockies Venture Club and the City of Fort Collins will host a special event celebrating Northern Colorado startups on Oct. 5. Accelerate Northern Colorado Angel Investors... Read More

Friday September 30, 2016 0 comments Tags: Fort Collins, Rockies Venture Club, City of Fort Collins, Galvanize FoCo, Sam Houghteling, Charisse Bowen, Jes Rawley, Terry Opgenorth, Jesse Elliot, Alan Curits, Denny Otsuga, Stow, Vartega Carbon Fiber, KromaTid, BillGO

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

By Steve Porter LOVELAND Theres a new approach to treating cancer and other diseases that aims to be less costly and more effective than traditional methods. Its called precision... Read More

By: Steve Porter Monday August 1, 2016 0 comments Tags: Loveland, NoCoBio Cluster, Innosphere, Deanna Scott, Chris Tompkins, Biodesix, Paul Beresford, KromaTid, Steven Schuster, UCHealth North, Alan Rudolph, Unsu Jung, MCR, Dana Stangel, Dr. Gary Luckasen